Adjuvant interferon in high-risk melanoma: End of the era?

Filip Janku; Razelle Kurzrock

doi:10.1200/JCO.2009.24.9326

Adjuvant interferon in high-risk melanoma: End of the era?

Filip Janku, Razelle Kurzrock

Graduate School of Biomedical Sciences

Research output: Contribution to journal › Letter › peer-review

13 Scopus citations

Original language	English (US)
Pages (from-to)	e15-e16
Journal	Journal of Clinical Oncology
Volume	28
Issue number	2
DOIs	https://doi.org/10.1200/JCO.2009.24.9326
State	Published - Jan 10 2010

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2009.24.9326

Cite this

@article{406cb5f8c39143f6884072a1e1e05631,

title = "Adjuvant interferon in high-risk melanoma: End of the era?",

author = "Filip Janku and Razelle Kurzrock",

year = "2010",

month = jan,

day = "10",

doi = "10.1200/JCO.2009.24.9326",

language = "English (US)",

volume = "28",

pages = "e15--e16",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "2",

}

TY - JOUR

T1 - Adjuvant interferon in high-risk melanoma

T2 - End of the era?

AU - Janku, Filip

AU - Kurzrock, Razelle

PY - 2010/1/10

Y1 - 2010/1/10

UR - http://www.scopus.com/inward/record.url?scp=74949129652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74949129652&partnerID=8YFLogxK

U2 - 10.1200/JCO.2009.24.9326

DO - 10.1200/JCO.2009.24.9326

M3 - Letter

C2 - 19949007

AN - SCOPUS:74949129652

SN - 0732-183X

VL - 28

SP - e15-e16

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 2

ER -

Adjuvant interferon in high-risk melanoma: End of the era?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this